Lipella pharmaceuticals unveils advanced bladder imaging technique at icicj conference

Pittsburgh, pa, august 21, 2024 – lipella pharmaceuticals inc. (nasdaq: lipo), a clinical-stage biotech company, will highlight clinical data on lp-20, a novel mri contrast agent designed for diagnosing interstitial cystitis and detecting bladder cancer at the 5th international consultation on interstitial cystitis japan (icicj) in kyoto, japan, taking place august 21-23, 2024.
LIPO Ratings Summary
LIPO Quant Ranking